Motus GI Holdings, Inc. (MOTS)
$3.93
-0.18 (-4.38%)
Rating:
Recommendation:
Neutral
| Symbol | MOTS |
|---|---|
| Price | $3.93 |
| Beta | 1.957 |
| Volume Avg. | 0.13M |
| Market Cap | 10.819M |
| Shares () | - |
| 52 Week Range | 3.6-17.4 |
| 1y Target Est | - |
| DCF Unlevered | MOTS DCF -> | |
|---|---|---|
| DCF Levered | MOTS LDCF -> | |
| ROE | -217.60% | Strong Sell |
| ROA | -97.56% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | 405.59% | Strong Buy |
| P/E | - | |
| P/B | 2.73 | Strong Buy |
Latest MOTS news
About
Download (Excel)Motus GI Holdings, Inc., a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.